International Journal of Clinical Oncology

Article	Citations
Clinical and biological impact of SNAT7 in lung adenocarcinoma: implications for prognosis and treatment	125
Long-term survival outcome of locally advanced gastric cancer patients who achieved a pathological complete response to neoadjuvant chemotherapy	98
Recent developments and future directions of first-line systemic therapy combined with immunotherapy for advanced or metastatic urothelial carcinoma: a historical perspective on treatment evolution	56
Predictive role of circulatory levels of high-mobility group box 1 for radiation pneumonitis in patients with non-small cell lung cancer treated with definitive thoracic radiotherapy	52
Online peer support for breast cancer survivors: protocol for a decentralized multicenter open-label pilot randomized controlled trial (HOPE-BC study)	33
Critical evaluation of “Long-term clinical outcome of lung radiofrequency ablation in patients with musculoskeletal sarcoma”	32
Indocyanine green-guided sentinel lymph node mapping during laparoscopic surgery with vaginal cuff closure but no uterine manipulator for cervical cancer	31
The prognostic impact of treatment centralization in patients with testicular germ cell tumors: analysis of hospital-based cancer registry data in Japan	30
Macroscopic and multiple metastases in sentinel lymph node biopsy are respectively associated with poor prognosis in early oral cancer	29
Efficacy of bepotastine compared with hydroxyzine in preventing rituximab-induced infusion-related reactions in non-hodgkin lymphoma patients: a phase II, double-blind, multicenter, and randomized tri	28
Onco-nephrology in clinical practice: pharmacokinetics, monitoring, and treatment strategies for patients with cancer and impaired renal function	27
Validation of the 9th Edition of the UICC TNM classification and the prognostic impact of nodal spread in salivary gland cancer	27
Identification of clinical prognosis features and significant DNA methylation regulation in pineoblastoma	26
Primary tumor location as a predictor of survival in patients with RAS wild-type colorectal cancer who receive molecularly targeted drugs as first-line therapy: a multicenter real-world observational	25
Breast cancer burden among women of reproductive age in China, Japan, and South Korea, 1990–2021: a systematic analysis from the Global Burden of Disease Study 2021	25
Socioeconomic disparities in colorectal cancer oncologic emergencies: a nationwide multilevel analysis in Japan	24
Local treatment for metastatic and primary sites in metastatic renal cell carcinoma in the combination immunotherapy era: a narrative review	23
Real-world application of comprehensive genomic profiling for gynecological malignancies: a multicenter observational study	23
Clinical outcomes and prognostic factors of concurrent chemoradiotherapy for anal squamous cell carcinoma in Japan	22
Prognostic value of myosteatosis in patients with lung cancer: a systematic review and meta-analysis	21
Rac1 activation in oral squamous cell carcinoma as a predictive factor associated with lymph node metastasis	21
Final analyses of the prospective controlled trial on the efficacy of uracil and tegafur/leucovorin as an adjuvant treatment for stage II colon cancer with risk factors for recurrence using propensity	21
Music therapy preferences among breast cancer patients undergoing perioperative chemotherapy: from qualitative insight to quantitative evidence	21
The efficacy and safety of lenvatinib plus pembrolizumab in vulnerable patients with metastatic or recurrent endometrial cancer: a single institution experience	21
Policy recommendations for promoting nuclear medicine therapy in Japan 2025, from the Working Group for promoting nuclear medicine therapy of the Japan Society of Clinical Oncology	20

Longitudinal assessment of health-related quality of life, sleep quality, and gustation in patients with advanced urothelial carcinoma receiving late-line enfortumab vedotin monotherapy	19
Concordance of BRAF V600E mutation between immunohistochemistry and genomic testing for thyroid cancer	18
Efficacy and safety of dose-dense chemotherapy for early-stage breast cancer under prophylactic pegfilgrastim administration: a systematic review and meta-analysis from clinical practice guidelines fo	18
Efficacy and safety of adjuvant nivolumab after radical surgery for high-risk urothelial carcinoma: a preliminary report of real-world data from a single institution	18
Can contralateral lymph-node metastases be ruled out in prostate cancer patients with only unilaterally positive prostate biopsy?	18
The efficacy of albumin–globulin ratio to predict prognosis in cancer patients	17
Functional outcomes at PICU discharge in hemato-oncology children at a tertiary oncology center in Hong Kong	17
Carcinogenesis and management of human papillomavirus-associated cervical cancer	17
High incidence of immune checkpoint inhibitor-induced pneumonitis in patients with non-small cell lung cancer and interstitial pneumonia, regardless of honeycomb lung or forced vital capacity: results	17
Prognostic significance of adjuvant chemotherapy in stage I–II endometrial carcinoma patients who underwent lymphadenectomy	17
Advances in endometrial cancer screening: a comprehensive review of current methods and emerging technologies	16
How to report and discuss subgroup analyses in clinical practice guidelines? Evaluation procedure of the clinical and statistical relevancy	16
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of alectinib and pembrolizumab for the adjuvant treatment of non-small cell lung cancer in Japa	16
Clinical utility of artificial intelligence assistance in histopathologic review of lymph node metastasis for gastric adenocarcinoma	16
Impact of immunohistochemistry-based molecular classification with conventional risk stratification on recurrence and survival outcomes in endometrial cancer	15
Correction: The efficacy and toxicity of metronomic oral vinorelbine monotherapy in patients with non-small cell lung cancer: a meta-analysis	15
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies	15
Non-pharmacological treatments for anticipatory nausea and vomiting during chemotherapy: a systematic review and meta-analysis of the Clinical Practice Guidelines for Antiemesis 2023	14
Phase 2 trial of crizotinib in Japanese patients with advanced NSCLC harboring a MET gene alteration: a Co-MET study	14
Cross-resistance among novel androgen receptor signaling inhibitors in non-metastatic castration-resistant prostate cancer	14
Optimizing pelvic lymph node dissection in bladder cancer: obturator focus, pN1 prognosis, and sentinel node feasibility	14
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; trastuzumab deruxtecan for solid tumors, talazoparib for prostate cancer, sacituzumab govitecan	13
Neutrophil-to-lymphocyte ratio at the end of treatment with CDK4/6 inhibitors is an independent prognostic factor for ER-positive HER2-negative advanced breast cancer	13
Clinical significance of antinuclear antibody as prognostic marker for first-line pembrolizumab in advanced non-small cell lung cancer	13
Advantages and limitations of estrogen replacement therapy on hypogonadal survivors of childhood cancer	13
The diagnostic potential of two exosome-derived circRNAs for papillary thyroid cancer	13
Comparison of surgical outcomes of robot-assisted radical prostatectomy between residents under our training curriculum and experienced surgeons: a propensity score-matched analysis	13
The diagnostic and prognostic value of tartrate-resistant acid phosphatase isoform 5b for giant cell tumor of bone	13
New predictors of microvascular invasion for small hepatocellular carcinoma ≤ 3 cm	13
The prognostic significance of the clinical T stage and Grade Group in patients with locally advanced prostate cancer treated via high-dose-rate brachytherapy and external beam radiation	12
Association of microbiota with cancer treatment	12
Deubiquitinases as prognostic biomarker and potential drug target for gynecological cancers	12
Investigation of tumor mutation burden using the comprehensive genomic profiling data of vulvar and vaginal malignant tumors: an observational study using C-CAT database	12
List of reviewers 2022–2023	12
Treatment outcomes of the patient with sinonasal mucosal melanoma: the role of endoscopic resection and postoperative radiotherapy	12
Survival benefit of using pemetrexed for EGFR mutation-positive advanced non-small-cell lung cancer in a randomized phase III study comparing gefitinib to cisplatin plus docetaxel (WJTOG3405)	12
Effectiveness and safety of primary prophylaxis with G-CSF for lung cancer: a systematic review and meta-analysis to develop clinical practice guidelines for the use of G-CSF 2022	12
Prognostic implications of morphological subtypes in a surgical cohort of perihilar cholangiocarcinoma: the overriding impact of nodal status	12
Glomerular filtration rate measurement during platinum treatment for urothelial carcinoma: optimal methods for clinical practice	12
Personalized prognostic model for colorectal cancer in the era of precision medicine: a dynamic approach based on real-world data	11
Severe weight loss during PD-1 treatment is a risk sign of poor prognosis for advanced GC patients	11
Radiotherapy with or without chemotherapy for locally advanced head and neck cancer in elderly patients: analysis of the Head and Neck Cancer Registry of Japan	11
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; encorafenib for colorectal cancer, daratumumab for multiple myeloma, repotrectinib for NTRK-fus	11
CD155 expression and co-expression with PD-L1 are not associated with poor prognosis in patients with stage II and III lung adenocarcinoma undergoing surgical resection	11
Comparison of the efficacy of enfortumab vedotin and paclitaxel plus carboplatin in patients with metastatic urothelial carcinoma	11
Robotic dual-docking surgery for para-aortic lymphadenectomy in endometrial cancer: a prospective feasibility study	11
Conversion surgical after neoadjuvant immunochemotherapy achieves survival comparable to initially resectable disease in borderline resectable esophageal cancer	11
Nationwide trends in mediastinal tumor and myasthenia gravis surgery in Japan: a decade claims-based analysis (2014–2023)	11
The curse of blood–brain barrier and blood–tumor barrier in malignant brain tumor treatment	11
Human papillomavirus testing and cytology using physician-collected uterine cervical samples vs. self-collected vaginal samples and urine samples	11

PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of sacituzumab govitecan for breast cancer, fruquintinib for colorectal cancer, amivantamab for	11
Influence of major hepatectomy on gemcitabine-based chemotherapy for recurrent biliary tract cancer after surgery: a subgroup analysis of JCOG1113	10
Muscle strength and functional recovery for soft-tissue sarcoma of the thigh: a prospective study	10
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in pati	10
The influence of UGT1A1 polymorphisms on modified FOLFIRINOX dose in double-variant-type patients with advanced pancreatic cancer	10
The efficacy of palbociclib and ribociclib in the first-line treatment of metastatic hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer in male patients: a Turk	10
Electronic patient-reported outcomes as digital therapeutics for patients with cancer: a narrative review of current practices and future directions	10
Celecoxib has less aggravating effect on cisplatin-induced nephrotoxicity in comparison with non-selective cyclooxygenase inhibitors: a retrospective multi-institutional study	10
Impact of time to first relapse on long-term outcome in adult retroperitoneal sarcoma patients after radical resection	10
Trends in incidence and hormonal management of endometrial cancer during potentially reproductive age in Japan: a population-based study	9
Ovarian serous borderline tumors with recurrent or extraovarian lesions: a Japanese, retrospective, multi-institutional, population-based study	9
Risk factors for second primary cancers in patients with curatively resected gastric cancer	9
A novel 5-differentially expressed gene (DEG) signature predicting the prognosis in patients with metastatic liver malignancies and the prognostic and therapeutic potential of SPP1	9
Correction to: Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies	9
Characterization of the mutational landscapes in Japanese patients with early-onset colorectal cancer from comprehensive genomic profiling data	9
Risk factors affecting delay of initiating adjuvant chemotherapy for stage III colorectal cancer	9
Discovery and validation of Hsa-microRNA-3665 promoter methylation as a potential biomarker for the prognosis of esophageal squaous cell carcinoma	9
A real-world study of treatment sequences and second-line clinical outcomes in patients with HER2-positive metastatic breast cancer in US community practice	9
Is daikenchuto effective for postoperative intestinal dysfunction after gastroenterological cancer surgery? An updated meta-analysis of randomized controlled trials	9
Intratumoral heterogeneity and chemotherapy-induced alteration of CLDN18.2 expression in resectable gastric cancer	9
Severe hypertension development significantly improves progression-free survival in regorafenib treatment for metastatic colorectal cancer	9
PIV and PILE scores predict the clinical outcome in patients with metastatic breast cancer treated with CDK4/6 inhibitors	9
Different outcomes by sex in metastatic gastrointestinal stromal tumor patients receiving imatinib: a trial-level analysis	9
Artificial intelligence predicts lymph node metastasis or risk of lymph node metastasis in T1 colorectal cancer	9
Treatment strategies and prognosis of superficial laryngo-pharyngeal cancer: a literature review	9
Physical activity and cancer biology: a narrative review of molecular mechanisms and introduction of the SCRUM-MONSTAR LIFELOG study	9
Correction to: Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study	9
Real-world outcomes of chimeric antigen receptor T-cell therapy with pembrolizumab as holding and/or bridging therapy in relapsed/refractory primary mediastinal large B-cell lymphoma	9
Association of chromosome 2 open reading frame 71 in colorectal cancer susceptibility	9
Conversion surgery for esophageal and esophagogastric junction cancer	8
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of pembrolizumab for gastric and biliary tract cancer and encorafenib and binimetinib for thyro	8
Stereotactic body radiotherapy for oligometastatic disease: current evidence and future perspectives	8
Incidence and molecular characteristics of deficient mismatch repair conditions across nine different tumors and identification of germline variants involved in Lynch-like syndrome	8
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs in Japan; imlunestrant for breast cancer, tafasitamab for follicular lymphoma, atezolizumab for thymic ca	8
Efficacy and safety of mycophenolate mofetil in patients with high-grade locally advanced or metastatic osteosarcoma (ESMMO): a multicenter, phase II clinical trial	8
Clinical outcomes of sentinel node navigation surgery in patients with preoperatively estimated stage IA endometrial cancer and evaluation of validity for continuing sentinel node navigation surgery b	8
Sentinel node navigation surgery in cervical cancer: a systematic review and metaanalysis	8
Clinical benefits of adding olanzapine to 5-HT3 receptor antagonist, NK1 receptor antagonist, and dexamethasone for the prevention of nausea and vomiting in highly emetogenic chemotherapy: a systemati	8
Future perspective of clinical usefulness of metabolic and mitochondrial heterogeneity in triple-negative breast cancers	8
EGFR mutation impacts recurrence in high-risk early-stage lung adenocarcinoma in the IASLC grading system	8
Outcomes of cases with complete hydatidiform mole coexisting with a fetus: a single-center study	8
Identification of risk factors for venous thromboembolism and validation of the Khorana score in patients with advanced lung cancer: based on the multicenter, prospective Rising-VTE/NEJ037 study data	8
Comparison of outcomes in high-risk prostate cancer patients treated with low-/high-dose-rate brachytherapy plus external beam radiotherapy	8
Modified EXTREME regimen versus modified TPEx regimen as first-line treatment for recurrent or metastatic head and neck squamous cell carcinoma: a multicenter, open-label, randomized, exploratory stud	8
Utility of comprehensive genomic profiling combined with machine learning for prognostic stratification in stage II/III colorectal cancer after adjuvant chemotherapy	8
Safety and oncologic outcomes of total laparoscopic versus abdominal hysterectomy following diagnostic conization for adenocarcinoma in situ and stage IA1 cervical cancer: a multicenter retrospective	8
Safety and pharmacokinetics of vepdegestrant in Japanese patients with ER+ advanced breast cancer: a phase 1 study	8
First-line treatment options for metastatic urothelial carcinoma: balancing efficacy, safety, and individual values and preferences through shared decision making	8
Clinical utility of a comprehensive genomic profiling test for patient with advanced biliary tract cancer	7
Clinicopathological characteristics of four major histological types of high-grade parotid carcinoma	7
Revisiting resectability of biliary tract cancers, in the triplet drug therapy era with immune checkpoint inhibitors	7
Prognostic role of hand grip strength (HGS) on outcomes after gastrectomy for gastric cancer: a systematic review and meta-analysis	7
Real-world outcomes of FOLFOXIRI plus bevacizumab in patients with metastatic colorectal cancer: the JSCCR-TRIPON study	7
Clinical outcomes of brain metastasectomy from soft tissue and bone sarcomas: a systematic review	7
Urological cancer statistics on incidence from 1975 to 2019 and mortality from 1958 to 2022 in Japan	7
Characteristics of gut microbiota in high-methylated colorectal cancer	7
Diagnostic performance of TILs–US score and LPBC in biopsy specimens for predicting pathological complete response in patients with breast cancer	7
Comparison of perioperative outcomes and complications between intracorporeal, extracorporeal, and hybrid ileal conduit urinary diversion during robot-assisted radical cystectomy: a comparative propen	7
Effectiveness and safety of primary prophylaxis of G-CSF during chemotherapy for prostate cancer, Japanese clinical guideline for appropriate use of G-CSF: clinical practice guidelines for the use of	7
Comment on: significance of preoperative mean corpuscular volume in patients with stage II/III colorectal cancer and anemia	7
Real-world clinical outcomes in Japanese patients with locally advanced squamous cell carcinoma of the head and neck treated with radiotherapy plus cetuximab: a prospective observational study (JROSG1	7
Effectiveness and safety of primary prophylaxis with G-CSF during chemotherapy for invasive breast cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the Use of G-CSF	7
Visceral adipose tissue-to-blood pool standardized uptake ratio by 18F-FDG–PET/CT predicts malnutrition and poor prognosis in patients with extrahepatic cholangiocarcinoma	7
Effectiveness of first-line combination chemotherapy in older patients with unresectable advanced gastric cancer: a retrospective study	7
Systematic review and meta-analysis of photon radiotherapy versus proton beam therapy for pediatric rhabdomyosarcoma: TRP-rhabdomyosarcoma 2024	7
A cross-sectional study on the first-in-human trials of anticancer drugs in Japan and the United States and the probability of approval	7
Clinical course of longer than five years after definitive radiotherapy for nasopharyngeal carcinoma	7
PMDA regulatory update on approval and revision of the precautions for use of anticancer drugs; approval of atezolizumab for alveolar soft part sarcoma, epcoritamab for follicular lymphoma, and isatux	7
CT-derived skeletal muscle change before immunotherapy predicts survival of advanced gastric cancer: associations with inflammatory markers and liver lipid metabolism	7
Distribution of Geriatric 8 screening tool scores in elderly and non-elderly patients with cancer	7
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab	7
Oncology drug lag in Japan: has it improved over the last decade?	7
Comparison between a single dose of PEG G-CSF and multiple doses of non-PEG G-CSF: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF 2022	7
Systematic surveillance of immune-related adverse events in clinical practice and impact of subsequent steroid medication on survival outcomes	7
Final efficacy and safety results and biomarker analysis of a phase 2 study of cabozantinib in Japanese patients with advanced renal cell carcinoma	7
Long-term consequences of positive surgical margin after partial nephrectomy for renal cell carcinoma: multi‐institutional analysis	7
Usefulness of dual isotope 123I-IMP and 201Tl SPECT for the diagnosis of primary central nervous system lymphoma and glioblastoma	7
Phase 1 study evaluating safety and pharmacokinetics of tusamitamab ravtansine monotherapy in Japanese patients with advanced malignant solid tumors	7
Lynch syndrome screening in patients with young-onset extra-colorectal Lynch syndrome-associated cancers	7
A phase II study evaluating the preventive effect of topical hydrocortisone for capecitabine-induced hand-foot syndrome in patients with colorectal cancer receiving adjuvant chemotherapy with capecita	7

Clinical characteristics of newly detected pharyngo-laryngeal lesions during transoral endoscopic surgery	7
Current clinical perspective of urological oncology in the adolescent and young adult generation	7
Prospective changes in financial toxicity and health-related quality of life in patients with gynecologic cancer	7
Phase I dose-escalation study on irinotecan, cisplatin, and S-1 combination in chemotherapy-naïve patients with HER2-negative advanced gastric cancer (HERBIS-4B, OGSG 1106)	7
Real-world safety and efficacy of immune checkpoint inhibitors in Japanese patients with persistent, recurrent, or metastatic cervical cancer: a multicenter prospective and retrospective study	7
Concurrent chemoradiotherapy with weekly low-dose carboplatin for cisplatin-ineligible patients with head and neck squamous cell carcinoma: survival analysis based on 2-year follow-up data	7
Comparison of first-line immuno-oncology combinations with molecular targeted therapy in patients with advanced renal cell carcinoma undergoing hemodialysis: a real-world multicenter retrospective stu	7
Efficacy and safety of mosunetuzumab monotherapy for Japanese patients with relapsed/refractory follicular lymphoma: FLMOON-1	7
Current advances and challenges in minimally invasive esophagectomy	7
Impact of baseline regular magnesium oxide administration on chemotherapy-induced constipation during cisplatin-containing treatment	7
Efficacy and safety of fruquintinib in patients with refractory metastatic colorectal cancer: a FRESCO-2 subgroup analysis of patients enrolled in Japan	7
Pterygomandibular raphe invasion as a novel grading and prognostic factor for squamous cell carcinoma of buccal mucosa: a retrospective study with propensity score matching	6
Effect of a web-based fertility preservation training program for medical professionals in Japan	6
Prognostic impact of lymphadenectomy in patients with advanced ovarian clear cell carcinoma: an ancillary analysis of the JGOG3017-A4 study	6
The new era of AML therapy: current standards and emerging targets	6
Clinical and imaging features of interstitial lung disease in cancer patients treated with trastuzumab deruxtecan	6
Clinical advantage of transmediastinal esophagectomy in terms of postoperative respiratory complications	6
Anti-HER2 plus endocrine therapy versus anti-HER2 plus chemotherapy in hormone receptor-positive and HER2-positive metastatic breast cancer: a retrospective study	6
Prognostic factors and effect of existing predictive models in oligo-metastatic urothelial carcinoma (YUSHIMA study)	6
Genomic landscape of cutaneous, acral, mucosal, and uveal melanoma in Japan: analysis of clinical comprehensive genomic profiling data	6
High RRN3 expression is associated with malignant characteristics and poor prognosis in pancreatic cancer	6
Clinical factors predicting the outcome of salvage radiotherapy for patients with biochemical recurrence after radical prostatectomy	6
Local excision versus radical surgery for anal squamous cell carcinoma: a multicenter study in Japan	6
Association between hospital palliative care team intervention volume and patient outcomes	6
Genetic and molecular mechanisms in lung cancer with interstitial pneumonia	6
Correction to: Genomic landscape of comprehensive genomic profiling in patients with malignant solid tumors in Japan	6
Fusobacterium nucleatum load in MSI colorectal cancer subtypes	6
Microflora: a promising potential in the diagnosis and treatment of non-small cell lung cancer	6
Prognostic factors and management of elderly sarcoma in Japan: the population-based National Cancer Registry (NCR) in Japan	6
New therapeutic target molecules for gastric and gastroesophageal junction cancer	6
Correction to: Risk assessment in the patients with uterine cervical cancer harboring intermediate risk factors after radical hysterectomy: a multicenter, retrospective analysis by the Japanese Gyneco	6
A phase two trial evaluating FOLFIRI plus aflibercept after failure of FOLFOXIRI plus bevacizumab in patients with unresectable metastatic colorectal cancer	6
Survey of healthcare professionals’ awareness of appearance care for Japanese cancer patients and their institutions’ appearance care systems: report from the Japan Society of Clinical Oncology	6
The superselective intra-arterial infusion of cisplatin and concomitant radiotherapy (RADPLAT) is effective for metastatic lymph nodes in head and neck squamous cell carcinoma	6
An approach for improvement of the accuracy of cancer gene panel testing	6
Chemotherapy-related hand–foot syndrome and hand–foot skin reaction: a review of management and possible approaches for Asian patients by the Japanese pharmacist-led oncodermatology study team	6
Impact of skeletal muscle mass on the prognosis of patients undergoing neoadjuvant chemotherapy for resectable or borderline resectable pancreatic cancer	6
Correction to: Significance of upfront cytoreductive nephrectomy stratified by IMDC risk for metastatic renal cell carcinoma in targeted therapy era – a multi‑institutional retrospective study	6
Comprehensive circulating tumor DNA mutation profiling via CAPP-Seq liquid biopsy for cervical cancer	6
Prognostic impact of dose reduced S-1 adjuvant chemotherapy in patients with pancreatic ductal adenocarcinoma: a retrospective multicenter study	6
First-line pembrolizumab with or without chemotherapy for recurrent or metastatic head and neck squamous cell carcinoma: 5-year follow-up of the Japanese population of KEYNOTE‑048	6
Cachexia index as a prognostic indicator in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab: multicenter analysis	6
Long-term outcomes of D2 vs. D3 lymph node dissection for cT2N0M0 colorectal cancer: a multi‑institutional retrospective analysis	6
Correction to: Clinical usefulness of eribulin as first- or second-line chemotherapy for recurrent HER2-negative breast cancer: a randomized phase II study (JBCRG-19)	6
Efficacy and safety of second-line fluorouracil, leucovorin, and irinotecan plus ramucirumab according to prior first-line regimens in metastatic colorectal cancer: a multicenter retrospective study	6
Rubicon can predict prognosis in patients with pancreatic ductal adenocarcinoma after neoadjuvant chemoradiotherapy	6
Tumor immune microenvironment and clinical outcomes in stage IV urothelial cancer: YODO study	6
18F-PSMA-PET/CT in comparison with whole-body MRI and combination of conventional CT and bone scintigraphy for detection of recurrent disease in prostate cancer patients with rising PSA levels after i	6
Efficacy and safety of subcutaneous mosunetuzumab in combination with lenalidomide and as a monotherapy in Japanese patients with relapsed/refractory follicular lymphoma	6
Chapter 4: CKD treatment in cancer survivors, from Clinical Practice Guidelines for the Management of Kidney Injury During Anticancer Drug Therapy 2022	6
Association between lung immune prognostic index and survival of patients with metastatic urothelial carcinoma treated with pembrolizumab	6
Stage IA and IC adult granulosa cell tumors: Clinical features, long-term outcomes and prognostic factors in a 333-patient cohort over three decades	6
LH–RH agonist monotherapy for androgen receptor-positive recurrent and/or metastatic salivary gland cancer: a retrospective study	5
First-line nivolumab plus ipilimumab in metastatic non-small cell lung cancer: 5-year outcomes in Japanese patients from CheckMate 227 Part 1	5
Lower optimal dose of amrubicin for relapsed small-cell lung cancer: a retrospective study	5
Evaluation of drug lag and drug loss in Japan: participation in global phase III oncology trials	5
Intensity-modulated radiation therapy can reduce acute toxicities in long-course neoadjuvant radiation therapy combined with S-1 for locally advanced rectal cancer	5
Long-term results of chemoradiotherapy with elective nodal irradiation for resectable locally advanced esophageal cancer in three-dimensional planning system	5
Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series	5
Current status and prospects of breast cancer imaging-based diagnosis using artificial intelligence	5
Advances in the treatment of human epidermal growth factor receptor 2-positive gastric cancer	5
Genomic medicine advances for brain tumors	5
Locomotive syndrome in cancer patients: a new role of orthopaedic surgeons as a part of comprehensive cancer care	5
Appropriate definition of non-metastatic castration-resistant prostate cancer (nmCRPC) and optimal timing of androgen receptor signaling inhibitor (ARSI)	5
Effect of cancer cachexia on first-line chemotherapy in patients with advanced pancreatic cancer: a claims database study in Japan	5
PD-L1 expression and microsatellite instability (MSI) in cancer of unknown primary site	5
Pembrolizumab in advanced NSCLC patients with poor performance status and high PD-L1 expression: OLCSG 1801	5
Correction to: Definitive radiotherapy consisting of whole pelvic radiotherapy with no central shielding and CT-based intracavitary brachytherapy for cervical cancer: feasibility, toxicity, and oncolo	5
Pegfilgrastim for the management of neutropenia during neoadjuvant chemotherapy with docetaxel, cisplatin, and 5-fluorouracil in esophageal cancer patients	5
Clinical development of molecular residual disease (MRD) and multi-cancer early detection (MCED) using liquid biopsy multiomics with artificial intelligence (AI)	5
Lymphatic drainage patterns of malignant skin tumors in the head and neck region: a single-center retrospective study	5
Impact of prior COVID-19 infection on perioperative outcomes in non-small cell lung cancer patients: a prospective observational cohort study	5
Clinical advantages of two vs. three courses of neoadjuvant chemotherapy using docetaxel + cisplatin + 5-fluorouracil to improve preoperative nutritional status and mitigate decreasing skeletal muscle	5
Differences in efficacy of biweekly irinotecan plus cisplatin versus irinotecan alone in second-line treatment of advanced gastric cancer with or without prior gastrectomy	5
Trends in real-world outcomes of patients with metastatic renal cell cancer in the recent treatment era: a single-institution analysis	5
Age-related genomic alterations and chemotherapy sensitivity in osteosarcoma: insights from cancer genome profiling analyses	5
Development and validation of neoadjuvant rectal score-based signature nomograms to predict overall survival and disease-free survival in locally advanced rectal cancer: a retrospective, double center	5
Development and validation of a nomogram to predict overall survival in patients with redefined anaplastic thyroid carcinoma based on the SEER database	5
Real-world outcomes in patients with metastatic castration-resistant prostate cancer beyond progression after upfront androgen receptor signaling inhibitor	5
Diagnostic performance of fluorescence in situ hybridization (FISH) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis	5
Risk of mortality and other adverse outcomes from myocardial infarction in cancer survivors: a meta-analysis	5
Efficacy of cisplatin-based neoadjuvant chemotherapy and risk factors for residual extravesical disease in muscle-invasive bladder cancer: insights from a nationwide cohort	5
Correction to: Brigatinib in Japanese patients with tyrosine kinase inhibitor-naive ALK-positive non-small cell lung cancer: first results from the phase 2 J-ALTA study	5
Prognostic impact and survival outcomes of colon perforation in patients with metastatic colorectal cancer: a multicenter retrospective cohort study	5
Optimal timing of prophylactic pegylated G-CSF after chemotherapy administration for patients with cancer: a systematic review and meta-analysis from Clinical Practice Guidelines for the use of G-CSF	5
The impact of the American Society of Anesthesiology-Physical Status classification system on the treatment and prognosis of patients with esophageal cancer undergoing esophagectomy	5
Burden and trajectories of biliary tract malignancies in Taiwan from 1998 to 2022	5
Acid suppressants reduce the therapeutic effect of immune checkpoint inhibitors and increase the risk of acute kidney injury: a meta-analysis	5
Improved prognosis of de novo metastatic prostate cancer after an introduction of life-prolonging agents for castration-resistant prostate cancer	5
Distant parenchymal recurrence during long-term use of TTFields treatment for glioblastoma	5
Immune checkpoint inhibitors in the treatment of pleural mesothelioma: insights from real-world data	5
Prognostic and clinicopathological implications of mismatch-repair deficiency and MLH1 promoter methylation status in endometrial carcinoma	5
Beyond tumor mutational burden: a framework for immune-checkpoint blockade responsiveness in gastrointestinal cancers	5
Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Stu	5
Impact of medications on the efficacy of immune checkpoint inhibitors in patients with recurrent or metastatic head and neck cancer	5